Literature DB >> 16288887

Real-time in vitro measurement of GTP hydrolysis.

Adam Shutes1, Channing J Der.   

Abstract

Small GTPases require an active GTPase activity to function correctly in their cellular environment. Mutation of key residues involved in this activity renders the GTPase defective and the small G-protein constitutively active (GTP-locked). The GTPase activity is also a target for GTPase-activating proteins (GAPs) which act to attenuate GTPase signalling by accelerating the conversion of bound GTP to bound GDP. The measurement of GTP hydrolysis in vitro can therefore provide information on the intrinsic activity of the small GTPase (e.g., mutated GTPase activity) as well as help define GAP specificity. Current methods to measure GTP hydrolysis in vitro utilise either radioactivity-based filter-binding assays or measurements of GDP:GTP:P(i) ratios by high-performance liquid chromatography (HPLC). Both provide timed snapshots of the current GTP-bound state, can be prone to experimental errors, and do not provide a real-time observation of GTP hydrolysis. The method we describe here utilises a fluorescently labelled, phosphate-binding protein (PBP), which scavenges for free inorganic phosphate (P(i)). On binding of a single P(i), a change of protein conformation is coupled to a 7-fold increase in fluorescence of the fluorophore. This method therefore permits real-time monitoring of GTPase activity, through measurement of P(i) production. This review describes the process of preparing and labelling the PBP with the MDCC fluorophore, as well as an example of its use in measuring the GTPase activity of small GTPases. We also discuss the pros and cons, and implications of the technique in comparison to the radioactive and HPLC method of measuring the GTPase activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288887     DOI: 10.1016/j.ymeth.2005.05.019

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  10 in total

1.  Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer.

Authors:  Luisa F Escobar-Hoyos; Alex Penson; Ram Kannan; Hana Cho; Chun-Hao Pan; Rohit K Singh; Lisa H Apken; G Aaron Hobbs; Renhe Luo; Nicolas Lecomte; Sruthi Babu; Fong Cheng Pan; Direna Alonso-Curbelo; John P Morris; Gokce Askan; Olivera Grbovic-Huezo; Paul Ogrodowski; Jonathan Bermeo; Joseph Saglimbeni; Cristian D Cruz; Yu-Jui Ho; Sharon A Lawrence; Jerry P Melchor; Grant A Goda; Karen Bai; Alessandro Pastore; Simon J Hogg; Srivatsan Raghavan; Peter Bailey; David K Chang; Andrew Biankin; Kenneth R Shroyer; Brian M Wolpin; Andrew J Aguirre; Andrea Ventura; Barry Taylor; Channing J Der; Daniel Dominguez; Daniel Kümmel; Andrea Oeckinghaus; Scott W Lowe; Robert K Bradley; Omar Abdel-Wahab; Steven D Leach
Journal:  Cancer Cell       Date:  2020-06-18       Impact factor: 31.743

Review 2.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

Review 3.  New weapons to penetrate the armor: Novel reagents and assays developed at the NCI RAS Initiative to enable discovery of RAS therapeutics.

Authors:  Dominic Esposito; Andrew G Stephen; Thomas J Turbyville; Matthew Holderfield
Journal:  Semin Cancer Biol       Date:  2018-02-09       Impact factor: 15.707

4.  High-Throughput Assay for Profiling the Substrate Specificity of Rab GTPase-Activating Proteins.

Authors:  Ashwini K Mishra; David G Lambright
Journal:  Methods Mol Biol       Date:  2021

5.  Redox regulation of Rac1 by thiol oxidation.

Authors:  G Aaron Hobbs; Lauren E Mitchell; Megan E Arrington; Harsha P Gunawardena; Molly J DeCristo; Richard F Loeser; Xian Chen; Adrienne D Cox; Sharon L Campbell
Journal:  Free Radic Biol Med       Date:  2014-10-05       Impact factor: 7.376

6.  p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities.

Authors:  X-Y Yang; M Guan; D Vigil; C J Der; D R Lowy; N C Popescu
Journal:  Oncogene       Date:  2009-01-19       Impact factor: 9.867

7.  RUTBC2 protein, a Rab9A effector and GTPase-activating protein for Rab36.

Authors:  Ryan M Nottingham; Ganesh V Pusapati; Ian G Ganley; Francis A Barr; David G Lambright; Suzanne R Pfeffer
Journal:  J Biol Chem       Date:  2012-05-25       Impact factor: 5.157

8.  RUTBC1 protein, a Rab9A effector that activates GTP hydrolysis by Rab32 and Rab33B proteins.

Authors:  Ryan M Nottingham; Ian G Ganley; Francis A Barr; David G Lambright; Suzanne R Pfeffer
Journal:  J Biol Chem       Date:  2011-08-01       Impact factor: 5.157

9.  The molecular basis for immune dysregulation by the hyperactivated E62K mutant of the GTPase RAC2.

Authors:  Megan E Arrington; Brenda Temple; Antje Schaefer; Sharon L Campbell
Journal:  J Biol Chem       Date:  2020-07-07       Impact factor: 5.486

10.  Nucleolar GTP-Binding Protein 1-2 (NOG1-2) Interacts with Jasmonate-ZIMDomain Protein 9 (JAZ9) to Regulate Stomatal Aperture during Plant Immunity.

Authors:  Seonghee Lee; Clemencia M Rojas; Sunhee Oh; Miyoung Kang; Swarup Roy Choudhury; Hee-Kyung Lee; Randy D Allen; Sona Pandey; Kirankumar S Mysore
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.